Milestone Pharmaceuticals Azioni (NASDAQ: MIST)

Ultime notizie per Milestone Pharmaceuticals (NASDAQ:MIST) Azioni

Milestone Pharmaceuticals

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Milestone Pharmaceuticals Inc. - Common Shares

Milestone Pharmaceuticals Inc

Mist

MISTRAS Group Inc

Mister Car Wash Inc

HSBC analyst Saul Martinez downgrades Goldman Sachs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) from Buy to Hold and raises the price target from $569 to $608.

News

Downgrades

Price Target

Analyst Ratings

HSBC Downgrades Goldman Sachs Gr to Hold, Raises Price Target to $608

Needham analyst Chris Pierce reiterates TrueCar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUE#NASDAQ">TRUE</a>) with a Buy and maintains $5 price target.

Reiteration

TRUE

Needham Reiterates Buy on TrueCar, Maintains $5 Price Target

Cloud-enabled integrated diagnostics portfolio aims to unify workflows, improve access to critical insights, and drive better outcomes for patients

AMZN

Philips And AWS Expand Strategic Partnership To Boost Healthsuite Cloud Services And Drive Generative AI Workflows

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk on Monday slammed California&#8217;s <a href="https://www.benzinga.com/trading-ideas/movers/24/11/42175967/whats-going-on-with-tesla-stock-today-3">plans to shut the company&#8217;s electric vehicles out</a> from consumer rebates under a new proposal, calling it an &#8220;insane&#8221; decision.
What Happened: According to a Bloomberg&nbsp;report, California Governor&nbsp;Gavin Newsom&nbsp;outlined a new proposal on Monday to offer incentives for EV buyers in California if President-elect&nbsp;Donald Trump&nbsp;gets rid of the current federal $7,500 tax break for EV buyers when he returns to the White House early next year.
Newsom's team reportedly told Bloomberg that the new proposal includes "market-share limitations" that would exclude Tesla's popular EV models from tax credit eligibility.
&#8220;It&#8217;s about creating the market conditions for more of these car makers to take route,&#8221;&nbsp;the governor's office reportedly said while adding that the details could change following negotiations with the state legislature. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Even though Tesla is the only company who manufactures their EVs in California! This is insane. <a href="https://t.co/EhVeG2TYqT">https://t.co/EhVeG2TYqT</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1861145047124845054?ref_src=twsrc%5Etfw">November 25, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Musk responded to the report on social media platform X and wrote, &#8220;Even though Tesla is the only company who manufactures their EVs in California! This is insane.&#8221; The CEO added that the move would hurt jobs in California. 
U.S. representative from California&#8217;s 17th congressional district Ro Khanna also warned against the proposal in a social media post.
&#8220;Tesla makes over 550,000 vehicles in Fremont in my district &amp; employs over 20,000. Let&#8217;s not play politics with keeping manufacturing in California. It would be foolish to exclude Tesla,&#8221; Khanna wrote while also recounting the time the Biden administration kept Tesla and Musk out of a 2021 EV summit, subsequently turning the billionaire <a href="https://www.benzinga.com/news/24/11/41705641/elon-musks-mother-slams-biden-snubbing-tesla-at-ev-summit-3-years-ago-as-the-worst-thing-that-happen">towards Trump and the Republican Party</a>.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Tesla makes over 550,000 vehicles in Fremont in my district &amp; employs over 20,000. Let&#39;s not play politics with keeping manufacturing in California. It would be foolish to exclude Tesla. Have we learned nothing from snubbing <a href="https://twitter.com/elonmusk?ref_src=twsrc%5Etfw">@elonmusk</a> at the Biden EV summit? <a href="https://t.co/I0Jzx51eP7">https://t.co/I0Jzx51eP7</a>
&mdash; Ro Khanna (@RoKhanna) <a href="https://twitter.com/RoKhanna/status/1861255099684638955?ref_src=twsrc%5Etfw">November 26, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Tesla makes Model 3, Y, S, and X at the Fremont factory in California. The factory has a currently installed annual vehicle capacity of over 650,000 units. 
Last month, Musk said that Tesla started manufacturing in California despite the higher cost because he lived in the state.
Tesla bought its Fremont Factory from&nbsp;Toyota Motor&nbsp;in 2010. It was previously owned by&nbsp;NUMMI, a joint venture between&nbsp;General Motors&nbsp;and Toyota which ended when GM entered bankruptcy in 2009.
Musk has long been critical of California. He moved Tesla&#8217;s headquarters from California to Austin a few years ago citing disagreements with state policies.
Price Action: Tesla stock fell nearly 4% on Monday to close at $338.59, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>. Year-to-date, the Tesla stock is up 36.3%.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/space/24/11/42181019/spacex-falcon-heavy-to-launch-nasas-dragonfly-mission-to-saturns-largest-moon-in-2028">SpaceX Falcon Heavy To Launch NASA&#8217;s Dragonfly Mission To Saturn&#8217;s Largest Moon In 2028</a></li>
</ul>
Photos courtesy: Shutterstock

Tech

TSLA

Elon Musk Slams California's Proposal To Shut Tesla EVs Out Of Consumer Rebates In State: 'This Is Insane'

Deutsche Bank analyst Nicole Deblase downgrades Hubbell (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBB#NYSE">HUBB</a>) from Buy to Hold and lowers the price target from $493 to $473.

HUBB

Deutsche Bank Downgrades Hubbell to Hold, Lowers Price Target to $473

Earnings

Zhihu Q3 Adj EPADS $(0.01) Up From $(0.30) YoY, Sales $120.42M Down From $140.10M YoY

Piper Sandler analyst Brent Bracelin maintains MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) with a Overweight and raises the price target from $335 to $425.

Piper Sandler Maintains Overweight on MongoDB, Raises Price Target to $425

Contrary to growing concerns about <a href="https://www.benzinga.com/news/global/24/11/42180906/larry-summers-warns-trump-policies-could-trigger-far-larger-stimulus-to-inflation-than-bidens-actions-as-sp-500-surges-markets-go-up-markets-go-down">potential inflationary pressures</a> under President-elect Donald Trump&#8216;s administration, top economist Steve Hanke dismisses fears of a significant price surge, citing monetary policy and money supply as critical factors.
What Happened: In a recent interview with <a href="https://www.cnbc.com/video/2024/11/25/trumps-deregulation-will-not-affect-inflation-says-professor-of-economics.html">CNBC</a>, Hanke argued that the inflation trajectory depends more on Federal Reserve actions than proposed economic policies. &#8220;All this talk about Trump&#8217;s policies causing inflation to kick up again is just nonsense,&#8221; Hanke stated.
Hanke highlighted a critical economic indicator: the U.S. money supply, which has contracted since 2022. Historically, such contractions have preceded economic downturns. &#8220;The money supply is growing at 2.6% year-over-year, below my golden growth rate of 6%,&#8221; he explained.
The economist predicts inflation will fall below the Fed&#8217;s 2% target in 2025, challenging warnings from economists like former Treasury Secretary Larry Summers, who anticipates potential inflationary risks from proposed <a href="https://www.benzinga.com/news/global/24/11/42180906/larry-summers-warns-trump-policies-could-trigger-far-larger-stimulus-to-inflation-than-bidens-actions-as-sp-500-surges-markets-go-up-markets-go-down">tax cuts and trade policies</a>.
See Also: <a href="https://www.benzinga.com/24/11/42180029/ark-invest-shakes-up-portfolio-with-big-tesla-and-amazon-trades">Cathie Wood-Led Ark Invest&#8217;s Latest Portfolio Maneuver: Dumps Tesla And Palantir Shares, Buys Amazon And AMD Stock</a>
Why It Matters: Hanke praised the potential administration&#8217;s focus on economic deregulation, suggesting it could enhance GDP growth without triggering significant inflation. He referenced Scott Bessent, Trump&#8217;s potential Treasury Secretary pick, who has proposed strategies to mitigate potential inflationary impacts.
Market indicators currently show resilience. S&amp;P 500 tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) has gained 3.61% since Nov. 5, trading at $597.53 on Monday, while Nasdaq-100 Index tracked by Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) increased 2.92% during the same period to $506.59, <a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
The potential economic shifts come amid a complex fiscal landscape, with the U.S. federal budget deficit projected to reach $1.7 trillion in 2024 and the&nbsp;<a href="https://www.benzinga.com/government/24/10/41461338/imf-upwardly-revises-us-economic-growth-but-warns-under-current-policies-the-us-public-debt-is-not-s" target="_blank" rel="noreferrer noopener">debt-to-GDP ratio approaching 120%</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42181602/dow-sp-500-reach-fresh-highs-investor-sentiment-improves-fear-greed-index-remains-in-greed-zone">Dow, S&amp;P 500 Reach Fresh Highs: Investor Sentiment Improves, Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>
Image Via Flickr 
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a>

Economics

Federal Reserve

Economist Steve Hanke Brushes Off Trump Economic Worries As 'Nonsense,' Predicts Fed Will Bring Prices Below 2% In 2025

Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) has no immediate plans to significantly update its premium AirPods Max headphones, according to Mark Gurman.
What Happened: Taking to X, formerly Twitter, Bloomberg columnist Gurman stated that Apple could keep selling the AirPods Max headphones without any major updates for the foreseeable future.
According to him, the $550 device occupies a peculiar position: it's not successful enough to justify substantial research and development investment, yet it's not underperforming enough to discontinue.
See Also: <a href="https://www.benzinga.com/24/11/42155932/apple-black-friday-2024-get-up-to-200-in-gift-cards-on-iphones-macs-airpods-and-more-heres-everything-you-need-to-know">Apple&#8217;s 2024 Black Friday Deals: Gift Cards Over Discounts — Here&#8217;s What You&#8217;ll Get</a>
He noted the headphones still cater to a specific audience, as evidenced by their visibility in high-end gyms in cities like Los Angeles and New York.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">At this point, Apple has no real plan to meaningfully update AirPods Max. The headphones aren't a hot enough seller to justify new R&amp;D, but they're also not a big enough flop to kill them. If you've been to an overpriced gym in LA/NYC, you can see the $550 device has a market.
&mdash; Mark Gurman (@markgurman) <a href="https://twitter.com/markgurman/status/1860724463324570111?ref_src=twsrc%5Etfw">November 24, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It Matters: Apple's wearables, home, and accessories category saw revenue of $9.04 billion in the <a href="https://www.benzinga.com/news/earnings/24/10/41666494/apple-q4-earnings-revenue-beat-eps-beat-installed-base-hits-new-highs-iphone-sales-rise-as-apple-in">fiscal fourth quarter</a>, a slight drop from $9.32 billion in the same period last year.
While Apple leads the true wireless stereo (TWS) market with a 17% market share as of the third quarter of 2024 – this represents a sharp decline from 48.1% in 2019, signaling intensified competition, according to Statista.
Despite the lack of updates, the headphones remain a steady, albeit modest, contributor to Apple&#8217;s wearables ecosystem, which includes AirPods Pro and AirPods.
Apple continues to focus on its broader product lineup, with the iPhone leading revenue at $46.22 billion in the fourth quarter, while services revenue grew to $24.97 billion.
The Tim Cook-led company <a href="https://www.benzinga.com/news/earnings/24/10/41666494/apple-q4-earnings-revenue-beat-eps-beat-installed-base-hits-new-highs-iphone-sales-rise-as-apple-in">reported fiscal fourth-quarter revenue</a> of $94.9 billion, surpassing analyst projections of $94.56 billion, with adjusted earnings per share of $1.64, exceeding expectations of $1.60.
Price Action: Apple stock gained 1.3% on Monday to close at $232.87, but fell 0.18% in after-hours trading. Year-to-date, Apple&#8217;s shares are up 25.4%, according to <a href="https://benzinga.grsm.io/lxquj26b2sag">Benzinga Pro data</a>, slightly underperforming the Nasdaq 100 index which is up 25.8%.
Check out more of Benzinga's Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/11/42132104/huawei-to-launch-mate-70-smartphone-with-advanced-homegrown-chip-challenging-apple-in-china-amid-us-sanctions-report">Apple Faces New Challenge As Huawei Advances Domestic Chip Tech In Mate 70 Series Amid US Sanctions: Report</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Unsplash

AAPL

Apple Could Keep AirPods Max Headphones Around Without 'Meaningfully' Updating Them, Says Analyst: Here's Why

<h3>Companies Reporting Before The Bell</h3>
• Icecure Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICCM#NASDAQ">ICCM</a>) is projected to report quarterly loss at $0.08 per share on revenue of $708 thousand. 
• Tsakos Energy Navigation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEN#NYSE">TEN</a>) is projected to report quarterly earnings at $0.66 per share on revenue of $164.00 million. 
• Manchester United (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MANU#NYSE">MANU</a>) is expected to report quarterly loss at $0.29 per share on revenue of $194.49 million. 
• Best Buy Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) is projected to report quarterly earnings at $1.29 per share on revenue of $9.63 billion. 
• Kohl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) is likely to report quarterly earnings at $0.27 per share on revenue of $3.71 billion. 
• JM Smucker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SJM#NYSE">SJM</a>) is estimated to report quarterly earnings at $2.51 per share on revenue of $2.26 billion. 
• Dick's Sporting Goods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) is expected to report quarterly earnings at $2.69 per share on revenue of $3.03 billion. 
• Analog Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>) is projected to report quarterly earnings at $1.64 per share on revenue of $2.41 billion. 
• Titan Machinery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TITN#NASDAQ">TITN</a>) is projected to report quarterly earnings at $0.05 per share on revenue of $675.30 million. 
• Embecta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EMBC#NASDAQ">EMBC</a>) is projected to report quarterly earnings at $0.36 per share on revenue of $276.88 million. 
• Ucloudlink Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCL#NASDAQ">UCL</a>) is expected to report quarterly earnings at $0.07 per share on revenue of $26.70 million. 
• Zhihu (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZH#NYSE">ZH</a>) is estimated to report earnings for its third quarter. 
• Macy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>) is expected to report quarterly loss at $0.01 per share on revenue of $4.72 billion. 
• Burlington Stores (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) is estimated to report quarterly earnings at $1.55 per share on revenue of $2.56 billion. 
• H World Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTHT#NASDAQ">HTHT</a>) is estimated to report quarterly earnings at $0.69 per share on revenue of $933.86 million. 
• Cadeler (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDLR#NYSE">CDLR</a>) is likely to report earnings for its third quarter. 
• Abercrombie &amp; Fitch (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) is projected to report quarterly earnings at $2.22 per share on revenue of $1.18 billion. 
• American Woodmark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMWD#NASDAQ">AMWD</a>) is projected to report quarterly earnings at $2.37 per share on revenue of $458.29 million. 
• Cheche Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCG#NASDAQ">CCG</a>) is projected to report earnings for its third quarter. 
• MediWound (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDWD#NASDAQ">MDWD</a>) is projected to report quarterly loss at $0.44 per share on revenue of $6.01 million. 
<h3>Companies Reporting After The Bell</h3>
• JOYY (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YY#NASDAQ">YY</a>) is expected to report quarterly earnings at $0.92 per share on revenue of $562.00 million. 
• Iris Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) is estimated to report quarterly loss at $0.07 per share on revenue of $54.75 million. 
• 3D Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDD#NYSE">DDD</a>) is expected to report quarterly loss at $0.09 per share on revenue of $113.65 million. 
• Guess (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GES#NYSE">GES</a>) is expected to report quarterly earnings at $0.37 per share on revenue of $747.44 million. 
• Pinstripes Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNST#NYSE">PNST</a>) is projected to report quarterly loss at $0.21 per share on revenue of $30.59 million. 
• Urban Outfitters (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) is likely to report quarterly earnings at $0.85 per share on revenue of $1.34 billion. 
• Nordstrom (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JWN#NYSE">JWN</a>) is estimated to report quarterly earnings at $0.22 per share on revenue of $3.35 billion. 
• CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) is estimated to report quarterly earnings at $0.81 per share on revenue of $983.03 million. 
• Dell Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) is estimated to report quarterly earnings at $2.06 per share on revenue of $24.72 billion. 
• Nutanix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) is likely to report quarterly earnings at $0.32 per share on revenue of $572.16 million. 
• Arrowhead Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARWR#NASDAQ">ARWR</a>) is expected to report quarterly loss at $0.92 per share on revenue of $58.91 million. 
• Autodesk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) is likely to report quarterly earnings at $2.12 per share on revenue of $1.56 billion. 
• Workday (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) is projected to report quarterly earnings at $1.76 per share on revenue of $2.13 billion. 
• Ambarella (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMBA#NASDAQ">AMBA</a>) is expected to report quarterly earnings at $0.04 per share on revenue of $79.03 million. 
• Yxt.Com Group Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YXT#NASDAQ">YXT</a>) is likely to report earnings for its third quarter. 
• Noah Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOAH#NYSE">NOAH</a>) is estimated to report earnings for its third quarter. 
• PagerDuty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PD#NYSE">PD</a>) is projected to report quarterly earnings at $0.17 per share on revenue of $116.39 million. 
• HP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) is expected to report quarterly earnings at $0.93 per share on revenue of $14.00 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADSK

AMBA

AMWD

ARWR

BURL

CDLR

CRWD

DELL

EMBC

HTHT

ICCM

IREN

MANU

MDWD

NOAH

NTNX

PNST

TITN

URBN

WDAY

Earnings Scheduled For November 26, 2024

Amid growing concerns over potential trade tensions, Tim Cook, CEO of Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) , along with other prominent American business leaders, are in China this week. Their visit coincides with the &#8216;China International Supply Chain Expo&#8217; and includes meetings with Chinese officials. This comes as the prospect of a second Donald Trump presidency raises the specter of increased tariffs on Chinese goods.
What Happened: The&nbsp;second annual &#8216;China International Supply&nbsp;Chain Expo&#8217; commenced on Tuesday, marking Cook&#8217;s third visit to China this year. This is&nbsp;his first time attending the&nbsp;expo, underscoring the importance of&nbsp;the Chinese market for Apple&#8217;s operations. In&nbsp;a video interview with Chinese&nbsp;state media, Cook emphasized Apple&#8217;s dedication to China, stating,&nbsp;&#8220;We&#8217;re very committed to China,&nbsp;that&#8217;s the reason I have&nbsp;been here three times.&#8221;
Prior to the expo, Cook and other top executives met with Chinese Premier&nbsp;Li Qiang. The meeting, as reported by&nbsp;the American Chamber of Commerce&nbsp;in China, focused on enhancing economic and trade cooperation. Representatives from companies like Corning and Rio Tinto were also present.
See Also: <a href="https://www.benzinga.com/news/global/24/11/42132984/texas-governor-mandates-state-agencies-to-divest-from-china-will-defend-and-safeguard-itself-from-any-potential-threat?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Texas Governor Mandates State Agencies To Divest From China: &#8216;Will Defend And Safeguard Itself&#8230;From Any Potential Threat&#8217;</a>
The expo, organized by the China International Exhibition Center Group, emphasizes key supply chains, including advanced manufacturing and green technology. 
Why It Matters: The backdrop to this visit is the potential for heightened trade tensions between the U.S. and China. President-elect Trump has announced plans to <a href="https://www.benzinga.com/24/11/42178994/trump-says-he-will-impose-25-tariffs-on-canada-mexico-on-first-day-of-office-and-extra-tariffs-on-china-until-they-pay-attention">impose a 25% tariff </a>on products from Mexico and Canada and an additional 10% tariff on Chinese imports. This move, intended to address issues like illegal immigration and drug trafficking, could significantly impact global markets.
China, on the other hand, has expressed a <a href="https://www.benzinga.com/startups/24/11/41944793/china-pushes-for-win-win-as-u-s-tariff-threat-looms-what-it-means-for-global-markets">desire for cooperation</a> with the U.S., advocating for &#8220;mutual respect, peaceful coexistence, and win-win cooperation.&#8221; However, a senior adviser from Beijing has warned that Trump&#8217;s proposed tariffs <a href="https://www.benzinga.com/government/regulations/24/11/42058282/trumps-tariffs-could-have-severe-consequences-for-us-defense-sector-beijing-adviser-warns">could have severe consequences</a> for the U.S. economy, particularly affecting the defense sector reliant on affordable Chinese components.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42178994/trump-says-he-will-impose-25-tariffs-on-canada-mexico-on-first-day-of-office-and-extra-tariffs-on-china-until-they-pay-attention?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump Says He Will Impose 25% Tariffs On Canada, Mexico On First Day Of Office And Extra Tariffs On China Until They &#8216;Pay Attention&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Image via Shutterstock

General

Tim Cook Joins US Executives To Attend China Expo As Donald Trump Threatens Extra Tariffs On Sino Goods

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) executive Sendil Palani on Saturday termed the company&#8217;s direct-to-customer sales model as &#8220;an enormous challenge&#8221; hindered by laws of different states.
What Happened: &#8220;Tesla has been pursuing the direct-to-consumer model for two decades, and it has been an enormous challenge to pursue what we believe is the best model for customers,&#8221; Palani, Vice President of Finance at Tesla, said. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Tesla has been pursuing the direct-to-consumer model for two decades, and it has been an enormous challenge to pursue what we believe is the best model for customers. I spent a portion of this past week visiting our Northeast region, and was reminded about how these laws are…
&mdash; Sendil Palani (@sendilpalani) <a href="https://twitter.com/sendilpalani/status/1860408805848215696?ref_src=twsrc%5Etfw">November 23, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Palani was responding to comments from Rivian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) CEO RJ Scaringe. Scaringe <a href="https://insideevs.com/news/741992/rivian-ceo-dealer-model/">told</a> InsideEVs that the direct-to-customer sales model is faced with several hardships. 
&#8220;I think you essentially have, like, lots of dealers have paid for laws that make it really hard for us to interact directly with the consumer,&#8221; he said, remarking that it is &#8220;as close as you can get to corruption.&#8221;
Why It Matters: <a href="https://www.benzinga.com/news/23/07/33417968/tesla-showroom-to-come-up-on-tribal-land-in-connecticut-to-skirt-state-ban-on-direct-sales">Certain states </a>such as Louisiana prohibit direct-to-customer sales in an attempt to protect dealers. The laws to sell to customers without dealers as middlemen differ across states and their <a href="https://www.benzinga.com/news/20/01/15160476/tesla-and-michigan-reach-settlement-for-direct-delivery-to-customers">application, too, varies.</a> 
While Tesla&#8217;s local sales and delivery teams observe restrictions on sales activities and manage deliveries through a small number of licensed locations, company customers have to travel long distances to pick up vehicles, Palani said. 
&#8220;Sadly, this is common throughout much of the country, resulting in higher costs and a worse customer experience for the affected regions,&#8221; he added. 
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/space/24/11/42181019/spacex-falcon-heavy-to-launch-nasas-dragonfly-mission-to-saturns-largest-moon-in-2028">SpaceX Falcon Heavy To Launch NASA&#8217;s Dragonfly Mission To Saturn&#8217;s Largest Moon In 2028</a></li>
</ul>
Photo courtesy: Unsplash

RIVN

Rivian CEO, Tesla Exec Slam Restrictions On Direct-To-Customer Sales: RJ Scaringe Says It Is 'As Close As You Can Get To Corruption'

Business Outlook
For the fourth quarter of 2024, UCLOUDLINK expects total revenues to be between US$25.0 million and US$30.0 million, representing an increase of 15.2% to 38.2% compared to the same period of 2023.
The above outlook is based on current market conditions and reflects the Company's preliminary estimates of market and operating conditions and customer demand.

Guidance

UCLOUDLINK Expects Q4 Revenues Of $25M-$30M Vs. $26.95M Consensus

Ucloudlink Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCL#NASDAQ">UCL</a>) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $0.06 by 50 percent. This is unchanged from the same period last year. The company reported quarterly sales of $25.192 million which missed the analyst consensus estimate of $26.050 million by 3.29 percent. This is a 5.57 percent increase over sales of $23.863 million the same period last year.

Earnings Beats

Earnings Misses

Ucloudlink Group Q3 2024 GAAP EPS $0.09 Beats $0.06 Estimate, Sales $25.192M Miss $26.050M Estimate

Kohl&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) will release earnings results for the third quarter, before the <a href="https://www.benzinga.com/quote/KSS/earnings">opening bell on Tuesday, Nov. 26.</a>
Analysts expect Kohl&#8217;s to report quarterly earnings at 27 cents per share. That's down from 54 cents per share a year ago. The Menomonee Falls, Wisconsin-based company projects to report quarterly revenue of $3.71 billion, compared to $3.84 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Monday, Kohl&#8217;s said Chief Executive Officer Tom Kingsbury plans to step down as CEO, effective Jan. 15, 2025.
Kohl&#8217;s shares gained 7.7% to close at $18.34 on Monday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/TJX/analyst-ratings">analysts have rated the company</a> &lt;/em>&lt;/a> in the recent period.
<ul>
<li>Citigroup analyst Paul Lejuez maintained a Neutral rating and cut the price target from $19 to $18 on Nov. 18. This analyst has an accuracy rate of 64%.</li>
<li>JP Morgan analyst Matthew Boss downgraded the stock from Neutral to Underweight with a price target of $19 on Aug. 29. This analyst has an accuracy rate of 67%.</li>
<li>Evercore ISI Group analyst Michael Binetii maintained an In-Line rating and cut the price target from $22 to $20 on Aug. 29. This analyst has an accuracy rate of 65%.</li>
<li>Baird analyst Mark Altschwager maintained an Outperform rating and slashed the price target from $27 to $25 on Aug. 29. This analyst has an accuracy rate of 68%.</li>
<li>Telsey Advisory Group analyst Dana Telsey maintained a Market Perform rating with a price target of $23 on Aug. 28. This analyst has an accuracy rate of 60%.</li>
</ul>
Considering buying KSS stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="558" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26030252/image-270-1024x558.png" alt="" class="wp-image-664883" style="width:571px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26030252/image-270-1024x558.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26030252/image-270-300x163.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26030252/image-270-768x418.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26030252/image-270.png 1157w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42174548/jim-cramer-says-this-stock-is-a-bitcoin-play-and-he-prefers-to-own-bitcoin">Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin</a></li>
</ul>

Pre-Market Outlook

Markets

Trading Ideas

Kohl's Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

ArcelorMittal is today providing an update on its decarbonization plans in Europe.
The Company has previously announced the intention to invest in lower carbon emissions "hydrogen ready" DRI-EAF facilities to replace several blast furnaces across our European business, as a key strategic first step towards reducing emissions. In all cases, the host countries offered funding support for these projects, with the approval of the European Commission.
These projects were premised on a favourable combination of policy, technology and market developments that would facilitate decarbonization investment by helping offset the significantly higher capital and operating costs that this transition strategy would involve. This included being able to use natural gas until green hydrogen became competitive.
However European policy, energy and market environments have not moved in a favourable direction. Green hydrogen is evolving very slowly towards being a viable fuel source and natural gas based DRI production in Europe is not yet competitive as an interim solution. Furthermore, there are significant weaknesses in the carbon border adjustment mechanism (CBAM), trade protection measures need strengthening in response to increasing imports due to overcapacity in China, and there is limited willingness among customers to pay premiums for low-carbon emissions steel.
Before taking final investment decisions it is necessary to have full visibility on the policy environment that will ensure higher cost steelmaking can be competitive in Europe without a global carbon price. &nbsp;&nbsp; We expect several important developments in 2025, including the scheduled review of the CBAM, an anticipated review of the steel safeguards, and the publication of the Steel and Metals Action Plan. When complete, these initiatives will provide the parameters needed to shape the business case for decarbonization investments in Europe.
In the meantime, we are continuing with engineering work, as well as analysing a phased approach that would first start with constructing electric arc furnaces, which can also be fed with scrap steel to significantly reduce emissions. &nbsp;&nbsp; ArcelorMittal remains committed to decarbonizing and achieving net-zero by 2050. Activity undertaken in Europe to date includes:
<ul>
<li>In May we commenced construction on a 1.1 million tonne capacity EAF at our long products plant in Gijón, Spain. This will ultimately lead to a reduction of 1 million tonnes of CO2e a year.</li>
<li>Good progress is being made with our efforts to increase production to 1.6 million tonnes a year by 2026 at our flat products plant in Sestao, Spain, where we have two EAFs. Once complete, much of this production will be our XCarb&#xAE; recycled and renewably produced low-carbon emissions steel.</li>
<li>We continue to lead the market with sales of our XCarb&#xAE; low-carbon emissions steel, which have a carbon footprint of as low as 300kg per tonne of steel produced, and are on track to double sales to c. 400,000 tonnes this year. &nbsp;</li>
</ul>
The longer timeline required for final investment decisions will not impact the Company's ability to meet customer demand for low-carbon emissions steel as the Sestao revamp project will materially increase the Company's ability to produce low-carbon emissions flat products.
Any revision to the current 2030 intensity targets will be set out in the forthcoming Climate Action Report 3. From an absolute emissions perspective, the absolute emissions of the Company's operations in Europe have reduced by 28.2% since 2018, largely due to lower production due to weak demand. &nbsp;&nbsp; Longer term, the Company remains committed to all technologies that offer the potential to take steelmaking to near-zero. This includes carbon capture utilisation and storage (CCUS), although like green hydrogen, this technology is likely to only make a meaningful difference after 2030. It already has one industrial scale CCU facility operational at its plant in Gent, Belgium, and a further two pilot projects underway in Gent.
Aditya Mittal, Chief Executive, ArcelorMittal, commented:
"ArcelorMittal remains absolutely committed to decarbonization. It is the right thing to do, both for the company and the planet. I remain confident that we can still achieve our net-zero by 2050 target, but the shape of how we will achieve this could differ from what was previously announced.
"We have been very grateful for the support offered to date by different governments to help accelerate this process. But the scale of the challenge requires further policy initiatives to unlock increased investment. We would have liked to move faster, but the reality is the regulatory environment required to support the business case for investments is not yet in place.
"I hope to see new policies coming into play that will support an accelerated transition. The Green Deal Industrial Plan and the Steel and Metals Action Plan, and the legislation flowing from them, will be important, as well as regulation to stimulate the demand signal. While we do have customers that want low-carbon steel, those that do and are willing to pay a premium are still very much in the minority. &nbsp;&nbsp; "I expect policy decisions taken in 2025 will help bring clarity on how we will move forward to decarbonize our assets, taking advantage of our unique global profile, superior technology and raw materials mix and industry leading innovation."
&nbsp;

ArcelorMittal Signals Shift in European Decarbonization Strategy Amid Policy Delays

The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, while the index remained in the &#8220;Greed&#8221; zone on Monday.
U.S. stocks settled higher on Friday, with the Dow Jones index and S&amp;P 500 hitting fresh records during the session. Major indices on Wall Street recorded gains last week, with the Dow gaining around 2% and the S&amp;P 500 adding around 1.7%.
Bath &amp; Body Works, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) shares jumped around 16.5% on Monday after the company reported better-than-expected third-quarter results and raised its 2024 outlook.
On the economic data front, the Chicago Fed National Activity Index fell to -0.40 in October compared to -0.27 in the previous month and versus market estimates of -0.20. The Dallas Fed's Texas manufacturing activity index rose to -2.7 in November compared to a reading of -3 in the previous month and versus market estimates of -2.4.
Most sectors on the S&amp;P 500 closed on a positive note, with real estate, materials, and consumer discretionary stocks recording the biggest gains on Monday. However, energy and information technology stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 440 points to 44,736.57 on Monday. The S&amp;P 500 rose 0.30% to 5,987.37, while the Nasdaq Composite rose 0.27% to close at 19,054.84 during Monday's session.
Investors are awaiting earnings results from Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>), HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>), and Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 61.5, the index remained in the &#8220;Greed&#8221; zone on Monday, versus a prior reading of 60.8.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42174548/jim-cramer-says-this-stock-is-a-bitcoin-play-and-he-prefers-to-own-bitcoin">Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin</a></li>
</ul>
Photo courtesy: Shutterstock

BBWI

Dow, S&P 500 Reach Fresh Highs: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone

NTRA

Reported Earlier, Natera To Present Latest Data On Signatera At 2024 San Antonio Breast Cancer Symposium

Elon Musk&#8216;s company, Neuralink, is set to initiate a new feasibility trial involving its innovative brain implant technology and a robotic arm. This trial aims to explore the safety and effectiveness of Neuralink&#8217;s wireless brain-computer interface and surgical robot.
What Happened: The study, named PRIME, will focus on patients with quadriplegia, enabling them to control external devices through thought, Reuters reported on Tuesday. Neuralink plans to enroll participants from its ongoing PRIME trial into this feasibility study, as mentioned in a post on social media platform X.
Recently, Neuralink received <a href="https://www.benzinga.com/24/11/42103314/elon-musks-neuralink-gets-green-light-to-launch-brain-chip-trial-in-canada-recruitment-is-now-open">approval from Health Canada</a> to conduct a trial of its device in Canada. Canadian neurosurgeons, in collaboration with Neuralink, have been authorized to recruit six patients with paralysis for the study. In the U.S., Neuralink has already implanted the device in two patients, allowing one to engage in activities such as playing video games and browsing the internet.
See Also: <a href="https://www.benzinga.com/news/24/11/42157649/trumps-doge-co-lead-elon-musk-slams-lockheed-martins-f-35-fighter-jets-advocates-drone-warfare-as-pentagon-defends-1-8-trillion-program?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump&#8217;s DOGE Co-Lead Elon Musk Slams Lockheed Martin&#8217;s F-35 Fighter Jets, Advocates Drone Warfare As Pentagon Defends $1.8 Trillion Program</a>
The company reports that the device is functioning well in the second patient, who is&nbsp;using it to play video&nbsp;games and learn 3D design. The U.S. FDA and Neuralink have not yet provided further&nbsp;details on the feasibility study.
Why It Matters: The potential of Neuralink&#8217;s brain chip technology to transform lives has been a topic of interest since Musk first introduced the concept. As reported in July, Musk <a href="https://www.benzinga.com/startups/24/07/40016299/we-want-to-give-people-super-powers-elon-musk-envisions-neuralink-brain-chip-transforming-lives-like">envisioned the brain chip </a>offering superhuman abilities, akin to characters from science fiction like Geordi La Forge from Star Trek. The company, founded in 2016, aims to revolutionize the way humans interact with technology and address neurological disorders through brain-computer interfaces (BCIs). 
The initial human trials began earlier this year with Noland Arbaugh, a 30-year-old quadriplegic, who received the N1 Implant, allowing him to control a computer cursor with his thoughts.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/42152721/tesla-cybertruck-part-of-donald-trumps-motorcade-will-vehicle-land-government-deals?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla Cybertruck Part Of Donald Trump&#8217;s Motorcade, Will Vehicle Land Government Deals?</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Elon Musk's Neuralink To Launch New Feasibility Trial With Brain Implant And Robotic Arm

With U.S. stock futures trading slightly higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) to report quarterly earnings at $1.29 per share on revenue of $9.63 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Best Buy shares rose 0.4% to $93.37 in after-hours trading.</li>
<li>Poseida Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTX#NASDAQ">PSTX</a>) agreed to be acquired by Roche in a $1.5 billion deal. Poseida Therapeutics shares jumped 11.2% to $3.18 in the after-hours trading session.</li>
<li>Analysts expect HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) to post quarterly earnings at 93 cents per share on revenue of $13.99 billion. The company will release earnings after the markets close. HP shares fell 0.3% to $39.19 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Zoom Video Communications, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) posted better-than-expected results for its third quarter and raised its guidance for the full year. Zoom reported third-quarter revenue of $1.18 billion, beating the consensus estimate of $1.16 billion. The communications company reported third-quarter adjusted earnings of $1.38 per share, beating analyst estimates of $1.31 per share. Zoom shares fell 5.6% to $84.09 in the after-hours trading session.</li>
<li>Analysts expect Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) to report quarterly earnings at $2.05 per share on revenue of $24.65 billion after the closing bell. Dell shares fell 0.8% to $143.00 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42174548/jim-cramer-says-this-stock-is-a-bitcoin-play-and-he-prefers-to-own-bitcoin">Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin</a></li>
</ul>
Photo courtesy: Flickr

PSTX

Best Buy, HP And 3 Stocks To Watch Heading Into Tuesday

In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research Report), wi...

Milestone Pharmaceuticals' CARDAMYST: A Game Changer in PSVT Treatment with Significant Market Potential

In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Milestone Pharmaceuticals (MIST – Research Report), with a price ta...

Milestone Pharmaceuticals (MIST) Receives a Buy from TD Cowen

"Our primary focus at Milestone is preparing for potential FDA approval of CARDAMYST nasal spray for the management of PSVT," said Joseph Oliveto, ...

Milestone Pharmaceuticals reports Q3 EPS (14c) vs. (35c) last year

Milestone Pharmaceuticals GAAP EPS of -$0.14

Milestone Pharmaceuticals (MIST) has released an update. Milestone Pharmaceuticals is gearing up for the potential FDA approval of its CARDAMYST na...

Milestone Pharmaceuticals Prepares for CARDAMYST Approval

16:40 EST Milestone Pharmaceuticals (MIST) files $250M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market...

Milestone Pharmaceuticals files $250M mixed securities shelf

Milestone Pharmaceuticals files for mixed shelf offering

TD Cowen analyst Ritu Baral maintained a Buy rating on Milestone Pharmaceuticals (MIST – Research Report) yesterday and set a price target of $9.00...

Strategic Positioning and Financial Outlook: Ritu Baral's Buy Rating on Milestone Pharmaceuticals Amidst Etripamil's Promising Market Launch

In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research Report), with ...

Comments

Milestone Pharmaceuticals

Notizie

Ultime notizie per Milestone Pharmaceuticals (NASDAQ:MIST) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO